Regenxbio (RGNX) Current Assets (2014 - 2026)
Regenxbio (RGNX) recorded Current Assets of $236.16 million in Q2 2026, down 36.8% from $373.75 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio reported Current Assets of $281.28 million, up 1.2% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $278 million in FY2024 (-17.0%), $334.97 million in FY2023 (-19.5%), $415.98 million in FY2022 (-19.8%) and $518.83 million in FY2021 (-2.3%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q4 2017.
- On a year-over-year basis, Current Assets rose in three of the last seven quarters, with an average decline of 10.6%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 7.8% in Q2 2025, against a decline of 36.8% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Regenxbio | 404.61 Mn | -528.48 Mn | - | 236.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 236.16 Mn |
| Dec 31, 2025 | 281.28 Mn |
| Sep 30, 2025 | 331.97 Mn |
| Jun 30, 2025 | 373.75 Mn |
| Mar 31, 2025 | 313.24 Mn |
| Dec 31, 2024 | 278.00 Mn |
| Sep 30, 2024 | 313.40 Mn |
| Jun 30, 2024 | 346.68 Mn |
| Mar 31, 2024 | 395.42 Mn |
| Dec 31, 2023 | 334.97 Mn |
| Sep 30, 2023 | 365.84 Mn |
| Jun 30, 2023 | 378.81 Mn |
| Mar 31, 2023 | 389.20 Mn |
| Dec 31, 2022 | 415.98 Mn |
| Sep 30, 2022 | 436.64 Mn |
| Jun 30, 2022 | 465.42 Mn |
| Mar 31, 2022 | 446.88 Mn |
| Dec 31, 2021 | 518.83 Mn |
| Sep 30, 2021 | 410.16 Mn |
| Jun 30, 2021 | 437.39 Mn |
API Access
Regenxbio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();